Deoxy technologies: a medical technology startup project: business plan for UK market

• Autor(a) principal: Henriques, Vanessa da Silva Mourato
• Data de Publicação: 2016
• Tipo de documento: Dissertação
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10071/15910
• topic: Medical devices; Innovation; Strategy; Lean startup; Gestão de empresas; Tecnologia médica; Nanotecnologia; Inovação; Análise estratégica; Política de saúde; Alemanha; Reino Unido

DEOXY Technologies is a seed-stage medical technology project whose future core business will be based on an innovative Gene Expression profiling (GEP) nanotechnology, developed and patented at Harvard University. The project is located at Ludwig-Maximilian University (Germany) and its goal is to develop diagnostic tests for clinical market where price, speed and automation are competitive advantages. DEOXY Technologies intends to become a global and "lean" company focused on development and manufacturing of molecular tests (in vitro medical devices). This is a strategic analysis and a feasibility study for the breast cancer market. Breast cancer is the most frequent female cancer affecting 12% of women, worldwide and is seen as a paradigm of precision medicine success. The promoter identifies a clinical application for the GEP technology and proposes an alliance with an USA biomarker-focused company whose assets are complementary to the technology. The strategic analysis was based on a macroenvironmental analysis for the entrance market: United Kingdom, where regulatory and reimbursement contexts were systematized, and for Germany the country of development and manufacturing, where the impact of governmental support and the integration in a biotechnology cluster are critical favorable factors. In the microenvironmental analysis the high barriers to entrance and the importance of planning an exit strategy were underlined. The economic and financial viability analysis revealed that governmental funding is a critical success factor, as demonstrated by the positivity of the APV and emphasized the importance of a market expansion plan before starting operations. The scenario analysis explored how reimbursement and healthcare policies may impact the economic and financial viability of the project.